{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3328"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3328","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"Manipulation of Cellular Proliferating Cell Nuclear Antigen (PCNA) During Herpes Simplex Virus Type 1 Infection","abstract":"Herpes simplex virus type 1 (HSV-1) is a double stranded DNA virus that replicates within the nucleus of host cells. Using accelerated native isolation of proteins on nascent DNA (aniPOND), cellular proteins were found to associate with HSV-1 replication forks. One host factor of interest is proliferating cell nuclear antigen (PCNA), the DNA sliding clamp that tethers DNA polymerases and DNA damage response proteins to replicating cellular DNA. Although HSV-1 encodes its own DNA polymerase processivity factor (UL42), PCNA plays a key role in HSV-1 infection. We used commercially available PCNA inhibitors and short hairpin RNAs (shRNA) to investigate how HSV-1 modifies, recruits, and utilizes PCNA. We found that PCNA inhibition results in decreased viral yield, a reduction in viral late mRNA and protein expression, and inhibits the association of select viral and cellular factors with replicating HSV-1 DNA. We also found by immunoprecipitation that PCNA copurifies with viral capsid, structural, and tegument proteins, specifically the viral deubiquitinase, UL36. We determined that PCNA ubiquitination peaks at 4 hpi and then decreases after the onset of viral DNA replication and late gene expression, perhaps due to UL36 activity. Finally, we used inducible shRNAs that target PCNA. We found that PCNA knockdown at 96-hours post doxycycline induction results in a 10-fold reduction in viral yield. These data reveal an important role for PCNA at viral replication forks in vivo, demonstrate that PCNA is modified during infection, and that PCNA inhibitors have the potential to be adapted for antiviral treatment against HSV-1 infection.","abstract_html":"Herpes simplex virus type 1 (HSV-1) is a double stranded DNA virus that replicates within the nucleus of host cells. Using accelerated native isolation of proteins on nascent DNA (aniPOND), cellular proteins were found to associate with HSV-1 replication forks. One host factor of interest is proliferating cell nuclear antigen (PCNA), the DNA sliding clamp that tethers DNA polymerases and DNA damage response proteins to replicating cellular DNA. Although HSV-1 encodes its own DNA polymerase processivity factor (UL42), PCNA plays a key role in HSV-1 infection. We used commercially available PCNA inhibitors and short hairpin RNAs (shRNA) to investigate how HSV-1 modifies, recruits, and utilizes PCNA. We found that PCNA inhibition results in decreased viral yield, a reduction in viral late mRNA and protein expression, and inhibits the association of select viral and cellular factors with replicating HSV-1 DNA. We also found by immunoprecipitation that PCNA copurifies with viral capsid, structural, and tegument proteins, specifically the viral deubiquitinase, UL36. We determined that PCNA ubiquitination peaks at 4 hpi and then decreases after the onset of viral DNA replication and late gene expression, perhaps due to UL36 activity. Finally, we used inducible shRNAs that target PCNA. We found that PCNA knockdown at 96-hours post doxycycline induction results in a 10-fold reduction in viral yield. These data reveal an important role for PCNA at viral replication forks in vivo, demonstrate that PCNA is modified during infection, and that PCNA inhibitors have the potential to be adapted for antiviral treatment against HSV-1 infection.","abstract_has_math":false,"creators":["Packard, Jessica","Dembowski, Jill A"],"institution":null,"degree_name":"PhD","degree_level":"Immediate Access","degree_discipline":"Biological Sciences","degree_department":null,"school":null,"contributors":["Jill Dembowski","Nancy Trun","Lauren O'Donnell","Michael Jensen-Seaman"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:52:32Z","subjects":["HSV-1","virus","viral infection","DNA replication","DNA","herpes simplex virus type 1","PCNA","proliferating cell nuclear antigen","Biology","Cell Biology","Microbiology","Virology"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/2305","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/2305","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3328","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jill Dembowski","Nancy Trun","Lauren O'Donnell","Michael Jensen-Seaman"]},{"key":"dc:creator","label":"Author","values":["Packard, Jessica","Dembowski, Jill A"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-03-24T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-08-01T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Immediate Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["HSV-1","virus","viral infection","DNA replication","DNA","herpes simplex virus type 1","PCNA","proliferating cell nuclear antigen","Biology","Cell Biology","Microbiology","Virology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/2305"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Herpes simplex virus type 1 (HSV-1) is a double stranded DNA virus that replicates within the nucleus of host cells. Using accelerated native isolation of proteins on nascent DNA (aniPOND), cellular proteins were found to associate with HSV-1 replication forks. One host factor of interest is proliferating cell nuclear antigen (PCNA), the DNA sliding clamp that tethers DNA polymerases and DNA damage response proteins to replicating cellular DNA. Although HSV-1 encodes its own DNA polymerase processivity factor (UL42), PCNA plays a key role in HSV-1 infection. We used commercially available PCNA inhibitors and short hairpin RNAs (shRNA) to investigate how HSV-1 modifies, recruits, and utilizes PCNA. We found that PCNA inhibition results in decreased viral yield, a reduction in viral late mRNA and protein expression, and inhibits the association of select viral and cellular factors with replicating HSV-1 DNA. We also found by immunoprecipitation that PCNA copurifies with viral capsid, structural, and tegument proteins, specifically the viral deubiquitinase, UL36. We determined that PCNA ubiquitination peaks at 4 hpi and then decreases after the onset of viral DNA replication and late gene expression, perhaps due to UL36 activity. Finally, we used inducible shRNAs that target PCNA. We found that PCNA knockdown at 96-hours post doxycycline induction results in a 10-fold reduction in viral yield. These data reveal an important role for PCNA at viral replication forks in vivo, demonstrate that PCNA is modified during infection, and that PCNA inhibitors have the potential to be adapted for antiviral treatment against HSV-1 infection."]},{"key":"dc:title","label":"Title","values":["Manipulation of Cellular Proliferating Cell Nuclear Antigen (PCNA) During Herpes Simplex Virus Type 1 Infection"]}]}],"canonical_facts":{"dc:contributor":["Jill Dembowski","Nancy Trun","Lauren O'Donnell","Michael Jensen-Seaman"],"dc:creator":["Packard, Jessica","Dembowski, Jill A"],"dc:date.available":["2025-03-24T07:00:00Z"],"dc:date.created":["2024-08-01T07:00:00Z"],"dc:description.abstract":["Herpes simplex virus type 1 (HSV-1) is a double stranded DNA virus that replicates within the nucleus of host cells. Using accelerated native isolation of proteins on nascent DNA (aniPOND), cellular proteins were found to associate with HSV-1 replication forks. One host factor of interest is proliferating cell nuclear antigen (PCNA), the DNA sliding clamp that tethers DNA polymerases and DNA damage response proteins to replicating cellular DNA. Although HSV-1 encodes its own DNA polymerase processivity factor (UL42), PCNA plays a key role in HSV-1 infection. We used commercially available PCNA inhibitors and short hairpin RNAs (shRNA) to investigate how HSV-1 modifies, recruits, and utilizes PCNA. We found that PCNA inhibition results in decreased viral yield, a reduction in viral late mRNA and protein expression, and inhibits the association of select viral and cellular factors with replicating HSV-1 DNA. We also found by immunoprecipitation that PCNA copurifies with viral capsid, structural, and tegument proteins, specifically the viral deubiquitinase, UL36. We determined that PCNA ubiquitination peaks at 4 hpi and then decreases after the onset of viral DNA replication and late gene expression, perhaps due to UL36 activity. Finally, we used inducible shRNAs that target PCNA. We found that PCNA knockdown at 96-hours post doxycycline induction results in a 10-fold reduction in viral yield. These data reveal an important role for PCNA at viral replication forks in vivo, demonstrate that PCNA is modified during infection, and that PCNA inhibitors have the potential to be adapted for antiviral treatment against HSV-1 infection."],"dc:identifier":["https://dsc.duq.edu/etd/2305"],"dc:language":["English"],"dc:subject":["HSV-1","virus","viral infection","DNA replication","DNA","herpes simplex virus type 1","PCNA","proliferating cell nuclear antigen","Biology","Cell Biology","Microbiology","Virology"],"dc:title":["Manipulation of Cellular Proliferating Cell Nuclear Antigen (PCNA) During Herpes Simplex Virus Type 1 Infection"],"thesis:degree_discipline":["Biological Sciences"],"thesis:degree_level":["Immediate Access"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:52:32Z"}